Farther Finance Advisors, LLC

Position in VTRS — Viatris Inc

CIK 1992825 SAN FRANCISCO, CA

Position in VTRS

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$582,510

+$297,144 QoQ

Shares Held

43,117

+88.1% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (10.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,645	$1,376,555
2	VTRS	Viatris Inc This page	43,117	$582,510
3	UTHR	UNITED THERAPEUTICS Corp	818	$485,057
4	HIMS	Hims & Hers Health, Inc.	20,825	$432,327
5	NBIX	Neurocrine Biosciences Inc	2,947	$388,237
6	COLL	Collegium Pharmaceutical, Inc	11,677	$386,158
7	TEVA	Teva Pharmaceutical Industries Ltd	11,152	$335,898
8	TAK	Takeda Pharmaceutical Co Ltd	17,828	$330,174

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$582,510	43,117	+88.1%	Shares	Sole	2026-04-07
2025-12-31	$285,366	22,921	+50.1%	Shares	Sole	2026-01-23
2025-09-30	$151,163	15,269	+7.9%	Shares	Sole	2025-10-14
2025-06-30	$126,341	14,148	+28.0%	Shares	Sole	2025-07-11
2025-03-31	$96,289	11,055	+0.2%	Shares	Sole	2025-04-14
2024-12-31	$137,385	11,035	+29.5%	Shares	Sole	2025-02-10
2024-09-30	$98,928	8,521	+9.9%	Shares	Sole	2024-10-29
2024-06-30	$82,403	7,752	+2.7%	Shares	Sole	2024-07-31
2024-03-31	$90,087	7,545	+21.0%	Shares	Sole	2024-05-14
2023-12-31	$67,514	6,234	+23.4%	Shares	Sole	2024-02-15
2023-09-30	$49,793	5,050	+10.8%	Shares	Sole	2023-11-14
2023-06-30	$45,468	4,556	+21.6%	Shares	Sole	2024-05-14
2023-03-31	$36,046	3,747	+45.2%	Shares	Sole	2024-05-14
2022-12-31	$28,726	2,581	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.